{"ABT": {"Ticker": "ABT", "Company": "Abbott Laboratories", "Sector": "Health Care", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$105"}, {"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$118"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$110"}], "Score": 0.67, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Jefferies", "Mizuho", "Barclays"], "Price_Target": 111.0}, "BKR": {"Ticker": "BKR", "Company": "Baker Hughes", "Sector": "Energy", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$29"}, {"Date": "2022-10-19", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$35"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies", "Wells Fargo"], "Price_Target": 32.0}, "BIIB": {"Ticker": "BIIB", "Company": "Biogen", "Sector": "Health Care", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$220 to $370"}, {"Date": "2022-10-13", "Rating": "Upgrade", "Organization": "Stifel", "Rating_Change": "Hold to Buy", "Target_Change": "$223 to $299"}, {"Date": "2022-10-07", "Rating": "Upgrade", "Organization": "Argus", "Rating_Change": "Hold to Buy", "Target_Change": "$300"}, {"Date": "2022-09-28", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$224 to $340"}, {"Date": "2022-09-28", "Rating": "Upgrade", "Organization": "Mizuho", "Rating_Change": "Neutral to Buy", "Target_Change": "$207 to $270"}, {"Date": "2022-09-28", "Rating": "Upgrade", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$217 to $360"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 6, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Stifel", "Robert W. Baird", "Argus", "Mizuho", "BMO Capital Markets", "Goldman"], "Price_Target": 323.17}, "GLW": {"Ticker": "GLW", "Company": "Corning", "Sector": "Information Technology", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Downgrade", "Organization": "Fox Advisors", "Rating_Change": "Overweight to Equal Weight", "Target_Change": ""}, {"Date": "2022-08-17", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$36"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Credit Suisse", "Fox Advisors"], "Price_Target": 36.0}, "DFS": {"Ticker": "DFS", "Company": "Discover Financial Services", "Sector": "Financials", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$104 to $116"}, {"Date": "2022-09-06", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$140 to $113"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["JP Morgan", "Morgan Stanley"], "Price_Target": 114.5}, "EW": {"Ticker": "EW", "Company": "Edwards Lifesciences", "Sector": "Health Care", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$100"}, {"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$96"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$110"}, {"Date": "2022-07-29", "Rating": "Downgrade", "Organization": "Canaccord Genuity", "Rating_Change": "Buy to Hold", "Target_Change": "$115 to $106"}], "Score": 1.25, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Jefferies", "Mizuho", "Canaccord Genuity", "Barclays"], "Price_Target": 103.0}, "HAL": {"Ticker": "HAL", "Company": "Halliburton", "Sector": "Energy", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Overweight", "Target_Change": "$52"}, {"Date": "2022-10-19", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$40"}, {"Date": "2022-10-07", "Rating": "Resumed", "Organization": "Piper Sandler", "Rating_Change": "Overweight", "Target_Change": "$36"}], "Score": 1.67, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 3, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Jefferies", "Wells Fargo", "Piper Sandler"], "Price_Target": 42.67}, "HUM": {"Ticker": "HUM", "Company": "Humana", "Sector": "Health Care", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Upgrade", "Organization": "Deutsche Bank", "Rating_Change": "Hold to Buy", "Target_Change": "$514 to $576"}, {"Date": "2022-09-20", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$494 to $549"}], "Score": 1.5, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["Deutsche Bank", "Morgan Stanley"], "Price_Target": 562.5}, "IVZ": {"Ticker": "IVZ", "Company": "Invesco", "Sector": "Financials", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Neutral to Underperform", "Target_Change": "$13 to $11.50"}, {"Date": "2022-10-19", "Rating": "Initiated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$13"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Credit Suisse"], "Price_Target": 13.0}, "MTCH": {"Ticker": "MTCH", "Company": "Match Group", "Sector": "Communication Services", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Resumed", "Organization": "Jefferies", "Rating_Change": "Buy", "Target_Change": "$90 to $60"}, {"Date": "2022-09-15", "Rating": "Initiated", "Organization": "Stifel", "Rating_Change": "Hold", "Target_Change": "$62"}, {"Date": "2022-09-14", "Rating": "Downgrade", "Organization": "Loop Capital", "Rating_Change": "Buy to Hold", "Target_Change": "$70 to $60"}, {"Date": "2022-08-03", "Rating": "Downgrade", "Organization": "Truist", "Rating_Change": "Buy to Hold", "Target_Change": "$145 to $68"}, {"Date": "2022-08-03", "Rating": "Downgrade", "Organization": "BTIG Research", "Rating_Change": "Buy to Neutral", "Target_Change": ""}], "Score": -0.2, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 5, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies", "Stifel", "BTIG Research", "Truist", "Loop Capital"], "Price_Target": 62.5}, "PNR": {"Ticker": "PNR", "Company": "Pentair", "Sector": "Industrials", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Underweight to Neutral", "Target_Change": "$42"}], "Score": 1.0, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "B", "Analists": ["JP Morgan"], "Price_Target": 42.0}, "REGN": {"Ticker": "REGN", "Company": "Regeneron Pharmaceuticals", "Sector": "Health Care", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Downgrade", "Organization": "Raymond James", "Rating_Change": "Mkt Perform to Underperform", "Target_Change": ""}, {"Date": "2022-10-17", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$760"}, {"Date": "2022-09-09", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$625 to $851"}, {"Date": "2022-09-09", "Rating": "Upgrade", "Organization": "Jefferies", "Rating_Change": "Underperform to Hold", "Target_Change": "$536 to $675"}], "Score": -0.25, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies", "Morgan Stanley", "Raymond James", "Evercore ISI"], "Price_Target": 762.0}, "TFX": {"Ticker": "TFX", "Company": "Teleflex", "Sector": "Health Care", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Neutral", "Target_Change": "$220"}, {"Date": "2022-10-14", "Rating": "Resumed", "Organization": "Stephens", "Rating_Change": "Overweight", "Target_Change": "$305"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Hold", "Target_Change": "$210"}, {"Date": "2022-07-29", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$248"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Jefferies", "Mizuho", "Wells Fargo", "Stephens"], "Price_Target": 245.75}, "WHR": {"Ticker": "WHR", "Company": "Whirlpool Corporation", "Sector": "Consumer Discretionary", "Updated": "2022-10-26", "Rating": [{"Date": "2022-10-26", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Underperform", "Target_Change": "$155 to $119"}], "Score": -2.0, "Cumulative_Rating": "Significant Underperform", "Number_of_Analysts": 1, "Period": "180 days", "Letter_Rating": "E", "Analists": ["BofA Securities"], "Price_Target": 119.0}}